The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients

BACKGROUND: Response rates of immune checkpoint inhibitor (ICI) therapy for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) are low. PATIENTS AND METHODS: This retrospective multicentre cohort study evaluates the predictive and prognostic value of weight loss and change...

Descripción completa

Detalles Bibliográficos
Autores principales: Willemsen, Anna C. H., De Moor, Nina, Van Dessel, Jeroen, Baijens, Laura W. J., Bila, Michel, Hauben, Esther, van den Hout, Mari F. C. M., Vander Poorten, Vincent, Hoeben, Ann, Clement, Paul M., Schols, Annemie M. W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134381/
https://www.ncbi.nlm.nih.gov/pubmed/36484469
http://dx.doi.org/10.1002/cam4.5522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134381/
https://www.ncbi.nlm.nih.gov/pubmed/36484469
http://dx.doi.org/10.1002/cam4.5522

Ejemplares similares